방사선종양학

본문글자크기
  • [Strahlenther Onkol.] Clinical safety and efficacy of salvage reirradiation for upper abdominal malignancies.

    연세의대 / 이준복, 성진실*

  • 출처
    Strahlenther Onkol.
  • 등재일
    2019 Jun
  • 저널이슈번호
    195(6):526-533. doi: 10.1007/s00066-018-01420-7. Epub 2019 Jan 28.
  • 내용

    바로가기  >

    Abstract
    PURPOSE:
    Reirradiation has the potential to provide effective local control of upper abdominal malignancies. This study aimed to evaluate the safety and efficacy of reirradiation for upper abdominal malignancies.

    METHODS:
    A total of 42 patients with a history of prior radiotherapy (RT) received reirradiation for abdominal malignancies between 2005 and 2017. Each patient's medical records, contours, and dose distribution for both RT courses were reviewed. The median dose of the prior RT was 50.0 Gy (range, 30.0-60.0 Gy) and the median dose of reirradiation was 45.0 Gy (range, 15.0-75.0 Gy).

    RESULTS:
    With a median follow-up of 10.9 months, the median infield-failure-free survival (IFFS) rate was 9.2 months. Gross tumor volume (GTV) significantly related to IFFS in both the univariate (p = 0.009) and multivariate analyses (p = 0.024), and patients with a GTV of <60.0 mL had an improved IFFS (p = 0.001). Four patients experienced ≥grade 3 late toxicities. In the retrospective dose reconstruction analysis in these patients, the cumulative dose to the most exposed 2 cc (D2cc) of the duodenum was >60.0 Gy (range, 60.1-73.7 Gy). In the univariate analysis, the D2cc of the duodenum and a preexisting duodenal ulcer identified using endoscopy prior to reirradiation significantly correlated with late severe toxicity (p = 0.021 and 0.017, respectively).

    CONCLUSIONS:
    Reirradiation for upper abdominal malignancies could be safely performed for patients without preexisting gastrointestinal morbidity unless the duodenum received excessive radiation doses. Reirradiation could also provide substantial IFFS, especially for patients with a GTV of <60.0 mL.

     


    Author information

    Lee JJB1, Choi SH1, Im JH1, Seong J2.
    1
    Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, 03722, Seoul, Korea (Republic of).
    2
    Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, 03722, Seoul, Korea (Republic of). jsseong@yuhs.ac.

  • 키워드
    Duodenum; Gross tumor volume; Local control; Radiotherapy dosage; Toxicity
  • 덧글달기
    덧글달기
       IP : 3.17.154.171

    등록